Exor N.V.

Concentrated strategyQuality / disciplined sizingLong-term holder

Total reported value

$5.4B

Reporting period: 2026-03-31 · Number of holdings: 3

Exor N.V. disclosed 3 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $5.4B and a quarterly turnover rate of 5.7%.

Browse other institutions with $1B to $10B AUM Browse other institutions starting with "E"

Personality snowflake

Concentration: 100
Portfolio Stability: 5.67
Momentum/Contrarian: 50
Sector conviction: 0
Diversification: 6
Sizing Uniformity: 84.52

Recent moves

Add 000000000
0.0%　$58.4M
Trim VIA
0.0%　-$197.8M
Trim CLVT
0.0%　-$54.5M

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

#	Ticker	Issuer	Asset Subclass	Weight	Weight Change	Shares Change
1	✓	Ikena Oncology INC	Stock-Other	92.90%	+4.27%	—
2	VIA	Via Transportation Inc-cl A	Stock-Other	3.93%	-3.41%	—
3	CLVT	Clarivate Plc	Stock-Other	3.16%	-0.87%	—

Reported value over time

Sector allocation

Not enough sector-mapped data yet

Sector allocation over time

Quarterly history

Period	Holdings	Total value	Stability	Top holdings
2026-03-31	3	$5.4B	6	10000002VIA 3CLVT Top holdings2026-03-31 1.000000 2.VIA 3.CLVT
2025-12-31	3	$5.6B	6	10000002VIA 3CLVT Top holdings2025-12-31 1.000000 2.VIA 3.CLVT
2025-09-30	3	$5.9B	24	10000002VIA 3CLVT Top holdings2025-09-30 1.000000 2.VIA 3.CLVT
2025-06-30	2	$4.7B	0	10000002CLVT Top holdings2025-06-30 1.000000 2.CLVT
2025-03-31	2	$4.7B	0	10000002CLVT Top holdings2025-03-31 1.000000 2.CLVT
2024-12-31	2	$4.5B	0	10000002CLVT Top holdings2024-12-31 1.000000 2.CLVT
2024-09-30	2	$5.9B	0	10000002CLVT Top holdings2024-09-30 1.000000 2.CLVT
2024-06-30	2	$4.5B	0	10000002CLVT Top holdings2024-06-30 1.000000 2.CLVT
2024-03-31	2	$3.3B	0	10000002CLVT Top holdings2024-03-31 1.000000 2.CLVT
2023-12-31	2	$3.9B	0	10000002CLVT Top holdings2023-12-31 1.000000 2.CLVT
2023-09-30	2	$3.0B	0	10000002CLVT Top holdings2023-09-30 1.000000 2.CLVT
2023-06-30	2	$905.4M	0	10000002CLVT Top holdings2023-06-30 1.000000 2.CLVT
2023-03-31	1	$304.9M	0	1CLVT Top holdings2023-03-31 1.CLVT
2022-12-31	1	$139.0M	0	1CLVT Top holdings2022-12-31 1.CLVT

Holding changes this quarter

Position changes disclosed by Exor N.V. for the quarter ending 2026-03-31, including ticker, issuer, weight change, shares change, and action
#	Ticker	Issuer	Weight Change	Shares Change	Action
1	✓	Ikena Oncology INC	+4.3%	—	Unchanged
2	CLVT	Clarivate Plc	-0.9%	—	Unchanged
3	VIA	Via Transportation Inc-cl A	-3.4%	—	Unchanged

FAQ

What is Exor N.V. and what type of investor is it?

Exor N.V. is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately $5.4B, spread across 3 disclosed positions.

What are Exor N.V.'s largest equity positions?

Based on the latest 13F filing, Exor N.V.'s top holdings by market value are: 1. Ikena Oncology INC — $5.0B (92.9%) 2. Via Transportation Inc-cl A (VIA) — $211.8M (3.9%) 3. Clarivate Plc (CLVT) — $170.3M (3.2%)

What changes did Exor N.V. make in its most recent portfolio filing?

No notable portfolio changes were recorded for Exor N.V. in the most recent quarter. Holdings appear to have remained relatively stable.

What sectors does Exor N.V. focus on?

Sector breakdown data is not yet available for Exor N.V.. Check back after the next 13F processing cycle.